Thermohydrogel Containing Melanin for Photothermal Cancer Therapy

Melanin is an effective absorber of light and can extend to near infrared (NIR) regions. In this study, a natural melanin is presented as a photothermal therapeutic agent (PTA) because it provides a good photothermal conversion efficiency, shows biodegradability, and does not induce long‐term toxici...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Macromolecular bioscience 2017-05, Vol.17 (5), p.n/a
Hauptverfasser: Kim, Miri, Kim, Hyun Soo, Kim, Min Ah, Ryu, Hyanghwa, Jeong, Hwan‐Jeong, Lee, Chang‐Moon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 5
container_start_page
container_title Macromolecular bioscience
container_volume 17
creator Kim, Miri
Kim, Hyun Soo
Kim, Min Ah
Ryu, Hyanghwa
Jeong, Hwan‐Jeong
Lee, Chang‐Moon
description Melanin is an effective absorber of light and can extend to near infrared (NIR) regions. In this study, a natural melanin is presented as a photothermal therapeutic agent (PTA) because it provides a good photothermal conversion efficiency, shows biodegradability, and does not induce long‐term toxicity during retention in vivo. Poloxamer solution containing melanin (Pol–Mel) does not show any precipitation and shows sol–gel transition at body temperature. After irradiation from 808 nm NIR laser at 1.5 W cm−2 for 3 min, the photothermal conversion efficiency of Pol–Mel is enough to kill cancer cells in vitro and in vivo. The tumor growth of mice bearing CT26 tumors treated with Pol–Mel injection and laser irradiation is suppressed completely without recurrence postirradiation. All these results indicate that Pol–Mel can become an attractive PTA for photothermal cancer therapy. Poloxamer solution containing melanin (Pol–Mel) shows sol–gel transition at body temperature after heat generation induced by near infrared 808 nm laser irradiation. Following intratumoral injection of Pol–Mel and the laser irradiation, the growth of the CT26 tumors is suppressed completely without recurrence. From these results, Pol–Mel is a potentially attractive photothermal therapeutic agent for cancer therapy.
doi_str_mv 10.1002/mabi.201600371
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1845254496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1898963463</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3731-2665e877f9c09c0e3035938e9c1e253e6a66b052d401abf8f70d15abc16e193</originalsourceid><addsrcrecordid>eNqF0M9LwzAUB_AgipvTq0cpePHSmdc0SXOcwx8Dh4K7l7R93TraZqYt0v_elM0JXoRA3uHzvjy-hFwDnQKlwX2lk2IaUBCUMgknZAwChM9B8dPjHMkRuWiaLaUgIxWck1EgFRUc6JjMVhu0ldn0mTVrLL25qVtd1EW99pZYajd4ubHe-8a0ph2odkbXKVpv2NS7_pKc5bps8OrwT8jH0-Nq_uK_vj0v5rNXP2WSgR8IwTGSMlcpdQ8ZZVyxCFUKGHCGQguRUB5kIQWd5FEuaQZcJykIBMUm5G6furPms8OmjauiSbF0J6LpmhiikAc8DJVw9PYP3ZrO1u42p1TkRCiYU9O9Sq1pGot5vLNFpW0fA42HauOh2vhYrVu4OcR2SYXZkf906YDag6-ixP6fuHg5e1j8hn8D-8mDxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1898963463</pqid></control><display><type>article</type><title>Thermohydrogel Containing Melanin for Photothermal Cancer Therapy</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Kim, Miri ; Kim, Hyun Soo ; Kim, Min Ah ; Ryu, Hyanghwa ; Jeong, Hwan‐Jeong ; Lee, Chang‐Moon</creator><creatorcontrib>Kim, Miri ; Kim, Hyun Soo ; Kim, Min Ah ; Ryu, Hyanghwa ; Jeong, Hwan‐Jeong ; Lee, Chang‐Moon</creatorcontrib><description>Melanin is an effective absorber of light and can extend to near infrared (NIR) regions. In this study, a natural melanin is presented as a photothermal therapeutic agent (PTA) because it provides a good photothermal conversion efficiency, shows biodegradability, and does not induce long‐term toxicity during retention in vivo. Poloxamer solution containing melanin (Pol–Mel) does not show any precipitation and shows sol–gel transition at body temperature. After irradiation from 808 nm NIR laser at 1.5 W cm−2 for 3 min, the photothermal conversion efficiency of Pol–Mel is enough to kill cancer cells in vitro and in vivo. The tumor growth of mice bearing CT26 tumors treated with Pol–Mel injection and laser irradiation is suppressed completely without recurrence postirradiation. All these results indicate that Pol–Mel can become an attractive PTA for photothermal cancer therapy. Poloxamer solution containing melanin (Pol–Mel) shows sol–gel transition at body temperature after heat generation induced by near infrared 808 nm laser irradiation. Following intratumoral injection of Pol–Mel and the laser irradiation, the growth of the CT26 tumors is suppressed completely without recurrence. From these results, Pol–Mel is a potentially attractive photothermal therapeutic agent for cancer therapy.</description><identifier>ISSN: 1616-5187</identifier><identifier>EISSN: 1616-5195</identifier><identifier>DOI: 10.1002/mabi.201600371</identifier><identifier>PMID: 27906510</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Animals ; Biocompatibility ; Biodegradability ; Body temperature ; Cancer ; Cancer therapies ; cancer therapy ; Cell Line, Tumor ; Chemical compounds ; Chemical precipitation ; Humans ; Hydrogels - chemistry ; Hyperthermia, Induced - methods ; Infrared Rays ; Irradiation ; Male ; Melanin ; Melanins - administration &amp; dosage ; Melanins - chemistry ; Melanins - therapeutic use ; Mice ; Mice, Inbred BALB C ; Neoplasms - therapy ; Pharmacology ; Phototherapy - methods ; Photothermal conversion ; photothermal therapy ; Poloxamer ; Sol-gel processes ; Temperature effects ; Therapy ; thermohydrogel ; Toxicity ; Tumors ; Xenograft Model Antitumor Assays</subject><ispartof>Macromolecular bioscience, 2017-05, Vol.17 (5), p.n/a</ispartof><rights>2016 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2016 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><rights>2017 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3731-2665e877f9c09c0e3035938e9c1e253e6a66b052d401abf8f70d15abc16e193</citedby><cites>FETCH-LOGICAL-c3731-2665e877f9c09c0e3035938e9c1e253e6a66b052d401abf8f70d15abc16e193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmabi.201600371$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmabi.201600371$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27906510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Miri</creatorcontrib><creatorcontrib>Kim, Hyun Soo</creatorcontrib><creatorcontrib>Kim, Min Ah</creatorcontrib><creatorcontrib>Ryu, Hyanghwa</creatorcontrib><creatorcontrib>Jeong, Hwan‐Jeong</creatorcontrib><creatorcontrib>Lee, Chang‐Moon</creatorcontrib><title>Thermohydrogel Containing Melanin for Photothermal Cancer Therapy</title><title>Macromolecular bioscience</title><addtitle>Macromol Biosci</addtitle><description>Melanin is an effective absorber of light and can extend to near infrared (NIR) regions. In this study, a natural melanin is presented as a photothermal therapeutic agent (PTA) because it provides a good photothermal conversion efficiency, shows biodegradability, and does not induce long‐term toxicity during retention in vivo. Poloxamer solution containing melanin (Pol–Mel) does not show any precipitation and shows sol–gel transition at body temperature. After irradiation from 808 nm NIR laser at 1.5 W cm−2 for 3 min, the photothermal conversion efficiency of Pol–Mel is enough to kill cancer cells in vitro and in vivo. The tumor growth of mice bearing CT26 tumors treated with Pol–Mel injection and laser irradiation is suppressed completely without recurrence postirradiation. All these results indicate that Pol–Mel can become an attractive PTA for photothermal cancer therapy. Poloxamer solution containing melanin (Pol–Mel) shows sol–gel transition at body temperature after heat generation induced by near infrared 808 nm laser irradiation. Following intratumoral injection of Pol–Mel and the laser irradiation, the growth of the CT26 tumors is suppressed completely without recurrence. From these results, Pol–Mel is a potentially attractive photothermal therapeutic agent for cancer therapy.</description><subject>Animals</subject><subject>Biocompatibility</subject><subject>Biodegradability</subject><subject>Body temperature</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>cancer therapy</subject><subject>Cell Line, Tumor</subject><subject>Chemical compounds</subject><subject>Chemical precipitation</subject><subject>Humans</subject><subject>Hydrogels - chemistry</subject><subject>Hyperthermia, Induced - methods</subject><subject>Infrared Rays</subject><subject>Irradiation</subject><subject>Male</subject><subject>Melanin</subject><subject>Melanins - administration &amp; dosage</subject><subject>Melanins - chemistry</subject><subject>Melanins - therapeutic use</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neoplasms - therapy</subject><subject>Pharmacology</subject><subject>Phototherapy - methods</subject><subject>Photothermal conversion</subject><subject>photothermal therapy</subject><subject>Poloxamer</subject><subject>Sol-gel processes</subject><subject>Temperature effects</subject><subject>Therapy</subject><subject>thermohydrogel</subject><subject>Toxicity</subject><subject>Tumors</subject><subject>Xenograft Model Antitumor Assays</subject><issn>1616-5187</issn><issn>1616-5195</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0M9LwzAUB_AgipvTq0cpePHSmdc0SXOcwx8Dh4K7l7R93TraZqYt0v_elM0JXoRA3uHzvjy-hFwDnQKlwX2lk2IaUBCUMgknZAwChM9B8dPjHMkRuWiaLaUgIxWck1EgFRUc6JjMVhu0ldn0mTVrLL25qVtd1EW99pZYajd4ubHe-8a0ph2odkbXKVpv2NS7_pKc5bps8OrwT8jH0-Nq_uK_vj0v5rNXP2WSgR8IwTGSMlcpdQ8ZZVyxCFUKGHCGQguRUB5kIQWd5FEuaQZcJykIBMUm5G6furPms8OmjauiSbF0J6LpmhiikAc8DJVw9PYP3ZrO1u42p1TkRCiYU9O9Sq1pGot5vLNFpW0fA42HauOh2vhYrVu4OcR2SYXZkf906YDag6-ixP6fuHg5e1j8hn8D-8mDxg</recordid><startdate>201705</startdate><enddate>201705</enddate><creator>Kim, Miri</creator><creator>Kim, Hyun Soo</creator><creator>Kim, Min Ah</creator><creator>Ryu, Hyanghwa</creator><creator>Jeong, Hwan‐Jeong</creator><creator>Lee, Chang‐Moon</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201705</creationdate><title>Thermohydrogel Containing Melanin for Photothermal Cancer Therapy</title><author>Kim, Miri ; Kim, Hyun Soo ; Kim, Min Ah ; Ryu, Hyanghwa ; Jeong, Hwan‐Jeong ; Lee, Chang‐Moon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3731-2665e877f9c09c0e3035938e9c1e253e6a66b052d401abf8f70d15abc16e193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Biocompatibility</topic><topic>Biodegradability</topic><topic>Body temperature</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>cancer therapy</topic><topic>Cell Line, Tumor</topic><topic>Chemical compounds</topic><topic>Chemical precipitation</topic><topic>Humans</topic><topic>Hydrogels - chemistry</topic><topic>Hyperthermia, Induced - methods</topic><topic>Infrared Rays</topic><topic>Irradiation</topic><topic>Male</topic><topic>Melanin</topic><topic>Melanins - administration &amp; dosage</topic><topic>Melanins - chemistry</topic><topic>Melanins - therapeutic use</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neoplasms - therapy</topic><topic>Pharmacology</topic><topic>Phototherapy - methods</topic><topic>Photothermal conversion</topic><topic>photothermal therapy</topic><topic>Poloxamer</topic><topic>Sol-gel processes</topic><topic>Temperature effects</topic><topic>Therapy</topic><topic>thermohydrogel</topic><topic>Toxicity</topic><topic>Tumors</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Miri</creatorcontrib><creatorcontrib>Kim, Hyun Soo</creatorcontrib><creatorcontrib>Kim, Min Ah</creatorcontrib><creatorcontrib>Ryu, Hyanghwa</creatorcontrib><creatorcontrib>Jeong, Hwan‐Jeong</creatorcontrib><creatorcontrib>Lee, Chang‐Moon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Macromolecular bioscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Miri</au><au>Kim, Hyun Soo</au><au>Kim, Min Ah</au><au>Ryu, Hyanghwa</au><au>Jeong, Hwan‐Jeong</au><au>Lee, Chang‐Moon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thermohydrogel Containing Melanin for Photothermal Cancer Therapy</atitle><jtitle>Macromolecular bioscience</jtitle><addtitle>Macromol Biosci</addtitle><date>2017-05</date><risdate>2017</risdate><volume>17</volume><issue>5</issue><epage>n/a</epage><issn>1616-5187</issn><eissn>1616-5195</eissn><abstract>Melanin is an effective absorber of light and can extend to near infrared (NIR) regions. In this study, a natural melanin is presented as a photothermal therapeutic agent (PTA) because it provides a good photothermal conversion efficiency, shows biodegradability, and does not induce long‐term toxicity during retention in vivo. Poloxamer solution containing melanin (Pol–Mel) does not show any precipitation and shows sol–gel transition at body temperature. After irradiation from 808 nm NIR laser at 1.5 W cm−2 for 3 min, the photothermal conversion efficiency of Pol–Mel is enough to kill cancer cells in vitro and in vivo. The tumor growth of mice bearing CT26 tumors treated with Pol–Mel injection and laser irradiation is suppressed completely without recurrence postirradiation. All these results indicate that Pol–Mel can become an attractive PTA for photothermal cancer therapy. Poloxamer solution containing melanin (Pol–Mel) shows sol–gel transition at body temperature after heat generation induced by near infrared 808 nm laser irradiation. Following intratumoral injection of Pol–Mel and the laser irradiation, the growth of the CT26 tumors is suppressed completely without recurrence. From these results, Pol–Mel is a potentially attractive photothermal therapeutic agent for cancer therapy.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27906510</pmid><doi>10.1002/mabi.201600371</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1616-5187
ispartof Macromolecular bioscience, 2017-05, Vol.17 (5), p.n/a
issn 1616-5187
1616-5195
language eng
recordid cdi_proquest_miscellaneous_1845254496
source Wiley-Blackwell Journals; MEDLINE
subjects Animals
Biocompatibility
Biodegradability
Body temperature
Cancer
Cancer therapies
cancer therapy
Cell Line, Tumor
Chemical compounds
Chemical precipitation
Humans
Hydrogels - chemistry
Hyperthermia, Induced - methods
Infrared Rays
Irradiation
Male
Melanin
Melanins - administration & dosage
Melanins - chemistry
Melanins - therapeutic use
Mice
Mice, Inbred BALB C
Neoplasms - therapy
Pharmacology
Phototherapy - methods
Photothermal conversion
photothermal therapy
Poloxamer
Sol-gel processes
Temperature effects
Therapy
thermohydrogel
Toxicity
Tumors
Xenograft Model Antitumor Assays
title Thermohydrogel Containing Melanin for Photothermal Cancer Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T15%3A25%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thermohydrogel%20Containing%20Melanin%20for%20Photothermal%20Cancer%20Therapy&rft.jtitle=Macromolecular%20bioscience&rft.au=Kim,%20Miri&rft.date=2017-05&rft.volume=17&rft.issue=5&rft.epage=n/a&rft.issn=1616-5187&rft.eissn=1616-5195&rft_id=info:doi/10.1002/mabi.201600371&rft_dat=%3Cproquest_cross%3E1898963463%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1898963463&rft_id=info:pmid/27906510&rfr_iscdi=true